The Qiaobing Xu Lab
Our group is at the forefront of lipid nanoparticle (LNP) technology. Our primary focus is developing biodegradable lipids for precise nucleic acid delivery, advancing LNPs for immunotherapy and vaccine efficacy, and pioneering non-viral vectors for efficient gene editing. Our work emphasizes innovation in drug delivery systems to enhance therapeutic discoveries and genomic interventions.